Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ferreira (Coimbra, Portugal), P. Bakke (Bergen, Norway), H. Ekroos (Porvoo, Finland), S. Soulard (Amsterdam, Netherlands), M. Haaksma-Herczegh (Amsterdam, Netherlands), M. MESTRES-SIMON (Barcelona, Spain), M. Águila-Fuentes (Barcelona, Spain), J. Kocks (Groningen, Netherlands), O. Van Schayck (Maastricht, Netherlands), N. Tzanakis (Creete, Greece), D. Cataldo (Liège, Belgium). Investigating the drivers for COPD treatment decisions. 2413

Member's Comments

No comment yet.

Related content which might interest you: Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Understanding patients' needs: the impact of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003 The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011 Predictors for adherence to COPD exacerbation action plans Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 Assessing COPD health: what do patients and physicians consider? Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Understanding patient’ adherence to inhaled medication: the social representations of COPD Source: International Congress 2017 – COPD management Year: 2017 What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020 Year: 2021 Understanding inequalities in COPD prevention and care policies across Europe Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 External validation of exacerbation and mortality outcomes of health economic decision models for COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 COPD self-management exacerbation action plans: predictors of adherence Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 The relationships between smoking and anxiety and depression in people with COPD – Implications for smoking cessation treatment for people with COPD Source: International Congress 2014 – Qualitative and quantitative research that contributes to respiratory nursing practice Year: 2014 Linking phenotypes to personalised treatments in asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Recognising and addressing the psychosocial and behavioural aspects of COPD and asthma patients Source: Annual Congress 2004 - Psychosocial and behavioural aspects of chronic respiratory diseases Year: 2004 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Gender differences in COPD treatment and morbidity in patients from the confronting COPD international survey Source: Eur Respir J 2003; 22: Suppl. 45, 216s Year: 2003 Life-sustaining treatment preferences of patients with severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Effects of pharmacist interventions to inhalation medication adherence and lung functions in COPD patients at one stop service clinic Source: International Congress 2014 – COPD exacerbations Year: 2014 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Impact of a self-management programme including self-treatment guidelines on exacerbations in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 594s Year: 2002